.......

Contact
FAQs
Feedback
Guarantee
Ingredients
Library
Newsletter
Order
Products
Subscribe
 
 
 
 

ArthriPhase: New Advanced Arthritis Support Formula

Jim English

Arthritis is a generic term for more than 100 different disorders, such as osteoarthritis, rheumatoid arthritis, gout and fibromyalgia. Osteoarthritis, or wear-and-tear arthritis, is the most prevalent and disabling of all chronic conditions, affecting approximately 80 percent of all U.S. adults over 65.

Osteoarthritis is a degenerative joint disease involving the loss of articular cartilage, the smooth, slippery tissue that covers the ends of bones to allow them to slide smoothly across each other as joints bend and flex.

Osteoarthritis can be caused by a variety of conditions (diabetes) or as a result of age-related thinning of cartilage. Obesity, which exerts mechanical stress on knee joints, is a recognized risk factor for osteoarthritis. Additionally, physical trauma, surgery, sports and occupational injuries are important factors for developing secondary osteoarthritis.

Osteoarthritis begins as a normal inflammatory response intended to protect joint tissues. For reasons not fully understood, the process goes awry, leading to degenerative changes in articular cartilage that cause the tissues to soften and swell up, making the cartilage less resistant to compressive forces and more susceptible to normal stresses. Continued use of the joint further inflames the surrounding synovial membranes and irritates the cartilage, leaving the once-smooth surface covered with pits and crevasses that further compromise the affected joint. Eventually, articular cartilage can be completely stripped from the bones, necessitating joint fusion or surgical replacement with artificial joints.

Treatment Options for Arthritis
There is currently no cure for arthritis and conventional medicine has little to offer beyond exercise (to increase joint flexibility), weight control (to reduce physical stress on the knees), and over-the-counter (OTC) or prescription anti-inflammatory and painkiller drugs to aid in managing arthritic symptoms.

NSAIDs
Non-steroidal anti-inflammatory drugs (NSAIDs) continue to be the primary treatment options for arthritic inflammation and pain. Unfortunately, popular over-the-counter NSAIDs such as aspirin, ibuprofen and naproxen, can cause stomach ulcers, GI bleeding and perforations when taken for extended periods. Additionally, NSAIDs block the synthesis of new collagen matrix, the body's main cartilage repair mechanism. By inhibiting this natural regenerative process, NSAIDs can temporarily dull pain and allow users to use their damaged joints completely unaware that they are actually speeding up the destruction of joint cartilage. In time, continuing joint damage exceeds the ability of NSAIDs to control pain, leading the patient to seek out more powerful analgesic agents.

COX-2 Inhibitors
The introduction of a new class of NSAIDs known as COX-2 inhibitors was initially hailed as a breakthrough in arthritic pain treatment due to their analgesic properties and a general lack of gastrointestinal side effects. COX-2 inhibitors work by reducing prostaglandins (chemical messengers) that cause pain and swelling. Unfortunately, COX-2 inhibitors also tend to increase risks of heart attacks and stroke by suppressing blood vessel dilation (vasodilation) and promoting formation of dangerous blood clots (thromboses).

Alternative Arthritis Options
Because of the risks associated with prescription and over-the-counter NSAIDs, use of alternative therapies, such as acupuncture, nutritional supplements and medicinal herbs, has risen sharply. Dissatisfied arthritis patients seeking nutritional support for arthritis have a wide range of choices, including natural compounds such as glucosamine, chondroitin sulfate, MSM and SAMe. Still, many find that success can be a hit or miss affair, requiring both luck and trial and error to determine which combination of supplements is most effective. Additionally, as with drugs, use of some supplements may be contraindicated due to interactions with pharmaceutical medications (i.e., warfarin, antidepressant drugs) and degenerative diseases such as diabetes and heart disease.

A Natural Alternative for Safe Pain Relief
Concern over the side effects associated with conventional arthritis therapies has sparked a renewed scientific interest in traditional natural arthritis remedies. A review of leading Chinese and English language medical journals reveals a surprising number of recently published studies detailing new insights into the biological and biochemical mechanisms of Chinese herbs historically used to safely relieve arthritic inflammation, pain and swelling.

Drawing on this wealth of new data, a team of Chinese medical researchers developed a new, advanced multi-herb formula that demonstrates a range of benefits previously unobtainable from conventional or alternative arthritis therapies. This formula, ArthriPhase™, is now available in the United States.

While each of the 12 herbs comprising the formula has a long history of use in traditional Chinese medicine, the unique efficacy demonstrated by ArthriPhase relies on each of the ingredients working in concert with the others to act on multiple biochemical pathways to provide analgesic, anti-inflammatory, and circulatory benefits. Since ArthriPhase does not rely on a single chemical in large quantity, like a drug, to get results, it is also very safe to use. The following is a brief review of specific benefits as revealed in recently published studies.

Relieving Chronic Arthritic Pains
Chronic pain is one of the most difficult problems for those coping with arthritis. According to the CDC, arthritic pain is the nation’s leading cause of chronic disability, and nearly 19 million U.S. adults report that arthritic pain severely limits their daily activities.

While never pleasant, not all pain is bad. Short-term, acute pain serves as the body’s alarm system, warning us of danger (minor cuts, insect bites, etc) while enabling us to learn from potentially damaging experiences. By contrast, the long-term pain associated with arthritis is a fixed, constant presence that is almost impossible to control.

Arthritic pain begins when specialized receptors (nociceptors) are activated following damage to joint tissues. This activation results in the release of pro-inflammatory prostaglandins and cytokines (chemical messengers) such as IL-1 and TNF-alpha. These chemicals stimulate the release of additional inflammatory enzymes that further damage cartilage while blocking the body’s efforts to initiate repairs. As inflammation worsens, joint tissues swell up and begin to compress pain nerves, resulting in degenerative nerve damage that triggers the release of even more inflammatory cytokines directly into the nerve roots. Over time this process alters the very structure of pain cells, causing them to become sensitized to the constant stimulus (Fig. 1). This process results in a lowering of pain threshold that directly amplifies pain signals while increasing sensitivity to pressure and temperature. In other words, the pain persists even after the original painful stimulus is no longer present.

Inflammation-induced pain responds poorly to currently available analgesics, making new compounds capable of relieving chronic arthritic pain an important target of intensive drug development.

One of the most important subjects of ongoing drug research involves a type of cell structure called a sodium channel. By controlling the flow of ions into and out of pain receptors (nociceptive neurons) sodium channels play a key role in the generation of pain signals. Blocking these sodium channels inhibits the transmission of pain signals from the nociceptive neurons, resulting in a localized anesthetic action and subsequent pain relief.

Of the 12 herbs comprising the ArthriPhase formula, seven demonstrate significant analgesic activity in animal studies. These herbs – Gastrodia, Tang-kuei, Notopterygium, Cyathula, Angelica Dahurica, Aconite and Scrophularia – have all been shown in animal studies to act on nociceptive neurons and pain pathways to relieve pain and calm over-sensitized nervous systems.

  • Aconite exhibits especially potent analgesic properties, according to a recent study conducted by researchers with the Department of Anesthesiology, Perioperative and Pain Medicine at Harvard Medical School. Their research reveals that one of the active ingredients in aconite – Bulleyaconitine A, or BLA – strongly reduces sodium channel currents to block overactive pain signals for prolonged periods of time. In China, BLA has been approved for the treatment of chronic pain and rheumatoid arthritis.
  • Scrophularia has demonstrated a powerful painkilling ability equal to that of cortisone and twice as effective as indomethacin, a popular NSAID used to treat arthritis. As with the other herbal ingredients, scrophularia exerts these significant analgesic effects with virtually no side effects.

Controlling Inflammation with ArthriPhase
Inflammation is the body’s front line defense against infection and damage. The five primary symptoms of inflammation – redness, heat, swelling, pain, and restriction of movement – are signs that the body is bringing in more blood and immune resources, such as white blood cells and macrophages, to remove microorganisms and other foreign matter. Redness is a sign that vasodilation is allowing more blood and other fluids to reach the affected area; local heat reflects the increased flow of warm blood from deep within the body; swelling (edema) is caused by the local accumulation of fluids; pain and restricted mobility arise from the added pressure caused by the swelling.

With osteoarthritis, inflammation is initially triggered either by trauma or irritation resulting from age-related damage to joint tissues. With the onset of inflammation the immune system responds by releasing additional pro-inflammatory factors (i.e., TNF-alpha, IFN-gamma, IL-1beta, IL-2, IL-4, LTB(4), and NO) that accelerate cartilage damage. In time the cartilage begins to degrade, shedding pieces of cartilage throughout the interior joint capsule. This new “foreign” material is, in turn, targeted for destruction by the immune system, further fueling the inflammatory response as the body struggles to eliminate the cellular debris. In time this process results in the eventual destruction of the joint.

Each of the herbs in ArthriPhase has been shown to exhibit potent anti-inflammatory properties. While specific mechanisms are unique to each herb (Table 1), the extraordinary balance of herbs in ArthriPhase exerts both short and long-term support for countering inflammation, dampening pain, reducing swelling and stiffness, and restoring cartilage integrity. Three herbs of special interest include Tang-kuei, Cyathula and Scrophularia.

  • Tang-kuei has been shown to reduce edema (swelling) in early and late stages of inflammation by decreasing leukocyte counts, neutrophil density, and interleukin-6 (IL-6) expression. Tang-kuei has also been found to increase levels of PGD2, a important natural anti-inflammatory prostaglandin. Most significantly, Tang-kuei is a natural source of ferulic acid, a potent antioxidant that protects cells from damaging reactive oxygen species (ROS) implicated in the pathology and progression of arthritis.
  • Cyathula inhibits collagen-induced arthritis and acute edema. Most significantly, two novel triterpene glycosides isolated from cyathula have been shown to be 1,000 times more potent than Sialyl Lewis X (SleX), an important blood group antigen that inhibits excess recruitment of neutrophils to injured tissues. This is an extremely important property. With arthritis, when too many white blood cells are recruited to an injured joint the neutrophils attack and destroy healthy tissues, leading to conditions such as septic shock and rheumatoid arthritis.
  • Scrophularia reduces edema, cell infiltration and proliferation of activated T-lymphocytes in damaged joint tissues. Additionally, scrophularia has been shown to inhibit a number of inflammatory factors, including prostaglandin E2, leukotriene B4, NO, interleukin-1beta, interleukin-2, interleukin-4, interferon-gamma and tumor necrosis factor-alpha (TNFa), but had no negative effect on the production of interleukin-10, a powerful anti-inflammatory cytokine. Moreover, scrophularia is the source of a unique glycoterpenoid, Verbascosaponin A, that is twice as potent as the NSAID indomethacin for relieving inflammation and pain.

Improved Joint Circulation
Arthritis results in impaired blood circulation to the joints, contributing to joint deterioration, cold sensations, weakness and stiffness. Advanced arthritis also inhibits ability to engage in physical exercise, further contributing to poor limb circulation. Arthritis-related changes to blood chemistry also increase risks of developing blood clots (thrombosis) in the veins and arteries, just the type of condition aggravated by COX-2 inhibitor drugs.

ArthriPhase contains several herbal ingredients shown to counter the negative effects of arthritic inflammation on circulation. One herb, gastrodia, has been shown to interact with human fibrinogen to act as a natural anticoagulant. By inhibiting interactions between fibrin molecules, gastrodia effectively inhibits the formation of arthritic-related thrombosis (blood clots) without interfering with normal clotting required for tissue maintenance.

In addition to improving blood flow to the joints, ArthriPhase’s circulatory benefits contribute to the overall safety profile of the formula, particularly when juxtaposed with the side-effects for conventional pain-killing and anti-inflammatory drugs.

Relaxing Joint Muscles and Supporting Collagen Synthesis
Arthritis causes painful swelling and stiffness that restricts joint movement. In time, limited movement leads to atrophy of the muscles surrounding the joints due to lack of use. Several herbs have been shown to relax arthritic joint muscles. Tang-kuei, in particular, has been shown in animal studies to exert a muscle relaxant effect to relax muscles and aid in restoring joint mobility.

Additionally, the herb eucommia has been shown to support recovery of joint mobility by promoting collagen synthesis. Researchers working with extracts of eucommia report that collagen synthesis was significantly increased when the herb was administered to laboratory rats raised to model age-related loss of joint cartilage.

Human Studies
In human clinical trials ArthriPhase has been shown to be highly effective in exerting a wide range of benefits, including anti-inflammatory, vasculoprotective, and immunomodulatory effects in arthritis and related diseases. In one study, 310 patients suffering arthritic joint pain received ArthriPhase for a period of 30 days. After only ten days, 70% of the patients reported marked reductions in primary arthritic pain. After 30 days, fully 50% of the patients had normal ESR (erythrocyte sedimentation rate) values. ESR is an important diagnostic test for measuring inflammation in arthritis. An increased ESR corresponds to increased non-specific inflammation in the body. Additionally, the blood test for rheumatoid factor (RF), a diagnostic marker for rheumatoid arthritis, had turned from positive to negative in 24 of 38 patients.

Immediate Benefits
The first benefit of the triple-acting ingredients is to provide quick pain relief. This fast-acting relief indicates that the analgesic, anti-inflammatory and circulatory actions are starting to reduce joint pain.

Long-Term Benefits
With continued use, people with arthritis can expect to see some long-term benefits when taking ArthriPhase daily for arthralgia in their joints. These improvements are also attributable to the triple-action benefits of the formula. In addition to enhancing comfort and flexibility, ArthriPhase users have also reported additional benefits, including memory improvement, normalization of blood pressure levels, and antispasmodic and sedative effects.

Short-Term Benefits
ArthriPhase supports restoration of healthy joint function while reducing pain, inflammation and swelling. The herbs in ArthriPhase contain multiple active ingredients that contribute to the overall benefits of the formula. The success of the formula relies on multiple beneficial actions exerted on many different chemical pathways to provide analgesic, anti-inflammatory, and circulatory benefits.

References
1. Ahn EK, Jeon HJ, Lim EJ, Jung HJ, Park EH. Anti-inflammatory and anti-angiogenic activities of Gastrodia elata Blume. J Ethnopharmacol. 2007 Apr 4;110(3):476-82. Epub 2006 Oct 19.
2. Lee JY, Jang YW, Kang HS, Moon H, Sim SS, Kim CJ. Anti-inflammatory action of phenolic compounds from Gastrodia elata root. Arch Pharm Res. 2006 Oct;29(10):849-58.
3. Liu Y, Tang X, Pei J, Zhang L, Liu F, Li K. Gastrodin interaction with human fibrinogen: anticoagulant effects and binding studies. Chemistry. 2006 Oct 16;12(30):7807-15.
4. Kim HM, An CS, Jung KY, Choo YK, Park JK, Nam SY. Rehmannia glutinosa inhibits tumour necrosis factor-alpha and interleukin-1 secretion from mouse astrocytes. Pharmacol Res. 1999 Aug;40(2):171-6.
5. Kim H, Lee E, Lee S, Shin T, Kim Y, Kim J. Effect of Rehmannia glutinosa on immediate type allergic reaction. Int J Immunopharmacol. 1998 Apr-May;20(4-5):231-40.
6. Kubo M, Asano T, Shiomoto H, Matsuda H. Studies on rehmanniae radix. I. Effect of 50% ethanolic extract from steamed and dried rehmanniae radix on hemorheology in arthritic and thrombosic rats. Biol Pharm Bull. 1994 Sep;17(9):1282-6.
7. Prieto JM, Recio MC, Giner RM, Máñez S, Giner-Larza EM, Ríos JL. Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions. J Pharm Pharmacol. 2003 Sep;55(9):1275-82.
8. Jung SM, Schumacher HR, Kim H, Kim M, Lee SH, Pessler F. Reduction of urate crystal-induced inflammation by root extracts from traditional oriental medicinal plants: elevation of prostaglandin D2 levels. Arthritis Res Ther. 2007 Jul 5;9(4):R64 [Epub ahead of print].
9. Wang H, Li W, Goldstein R, Tracey KJ, Sama AE. HMGB1 as a potential therapeutic target. Novartis Found Symp. 2007;280:73-85; discussion 85-91, 160-4.
10. Yang T, Jia M, Meng J, Wu H, Mei Q. Immunomodulatory activity of polysaccharide isolated from Angelica sinensis. Int J Biol Macromol. 2006 Nov 15;39(4-5):179-84. Epub 2006 Mar 6.
11. Yang T, Jia M, Mei Q. Effect of Angelica sinensis polysaccharide on lymphocyte proliferation and cytokine induction. Zhong Yao Cai. 2005 May;28(5):405-7.
12. Ozaki Y. Antiinflammatory effect of tetramethylpyrazine and ferulic acid.Chem Pharm Bull (Tokyo). 1992 Apr;40(4):954-6.
13. Ozaki Y, Sekita S, Harada M. Centrally acting muscle relaxant effect of phthalides (ligustilide, cnidilide and senkyunolide) obtained from Cnidium officinale Makino. Yakugaku Zasshi. 1989 Jun;109(6):402-6.
14. Zschocke S, Lehner M, Bauer R. 5-Lipoxygenase and cyclooxygenase inhibitory active constituents from Qianghuo (Notopterygium incisum). Planta Med. 1997 Jun;63(3):203-6.
15. Okuyama E, Nishimura S, Ohmori S, Ozaki Y, Satake M, Yamazaki M. Analgesic component of Notopterygium incisum Ting. Chem Pharm Bull (Tokyo). 1993 May;41(5):926-9.
15. Li Y, Kamo S, Metori K, Koike K, Che QM, Takahashi S. The promoting effect of eucommiol from Eucommiae cortex on collagen synthesis. Biol Pharm Bull. 2000 Jan;23(1):54-9.
16. Liang MJ, He LC. Inhibitory effects of ligustilide and butylidenephthalide on bFGF-stimulated proliferation of rat smooth muscle cells. Yao Xue Xue Bao. 2006 Feb;41(2):161-5.
17. Chan SS, Choi AO, Jones RL, Lin G. Mechanisms underlying the vasorelaxing effects of butylidenephthalide, an active constituent of Ligusticum chuanxiong, in rat isolated aorta. Eur J Pharmacol. 2006 May 10;537(1-3):111-7. Epub 2006 Mar 20.
18. Liu L, Ning ZQ, Shan S, Zhang K, Deng T, Lu XP, Cheng YY. Phthalide Lactones from Ligusticum chuanxiong inhibit lipopolysaccharide-induced TNF-alpha production and TNF-alpha-mediated NF-kappaB Activation. Planta Med. 2005 Sep;71(9):808-13.
19. Xi Bao Y, Kwok Wong C, Kwok Ming, et al. Immunomodulatory effects of lingzhi and san-miao-san supplementation on patients with rheumatoid arthritis. Immunopharmacol Immunotoxicol. 2006;28(2):197-200.
20. Han SB, Lee CW, Yoon YD, et al. Prevention of arthritic inflammation using an oriental herbal combination BDX-1 isolated from Achyranthes bidentata and Atractylodes japonica. Arch Pharm Res. 2005 Aug;28(8):902-8.
21. Lu T, Mao C, Zhang L, Xu W. Research on analgestic and anti-inflammatory action of different processed products of Achyranthes bidentata. Zhong Yao Cai. 1997 Oct;20(10):507-9.
22. Ida Y, Satoh Y, Katsumata M, et al. Two novel oleanolic acid saponins having a sialyl Lewis X mimetic structure from Achyranthes fauriei root. Bioorg Med Chem Lett. 1998 Sep 22;8(18):2555-8.
23. Bas E, Recio MC, Máñez S, Giner RM, Escandell JM, López-Ginés C, Ríos JL. New insight into the inhibition of the inflammatory response to experimental delayed-type hypersensitivity reactions in mice by scropoliosideA. Eur J Pharmacol. 2007 Jan 26;555(2-3):199-210. Epub 2006 Oct 17.
23. Bas E, Recio MC, Abdallah M, Máñez S, Giner RM, Cerdá-Nicolás M, Ríos JL. Inhibition of the pro-inflammatory mediators' production and anti-inflammatory effect of the iridoid scrovalentinoside. J Ethnopharmacol. 2007 Apr 4;110(3):419-27. Epub 2006 Oct 13.
24. Giner RM, Villalba ML, Recio MC, Máñez S, Cerdá-Nicolás M, Ríos J. Anti-inflammatory glycoterpenoids from Scrophularia auriculata. Eur J Pharmacol. 2000 Feb 18;389(2-3):243-52.
25. Schinella GR, Tournier HA, Prieto JM, Mordujovich de Buschiazzo P, Ríos JL. Antioxidant activity of anti-inflammatory plant extracts. Life Sci. 2002 Jan 18;70(9):1023-33.
26. Li YM, Han ZH, Jiang SH, Jiang Y, Yao SD, Zhu DY. Fast repairing of oxidized OH radical adducts of dAMP and dGMP by phenylpropanoid glycosides from Scrophularia ningpoensis Hemsl. Acta Pharmacol Sin. 2000 Dec;21(12):1125-8.
27. Su CR, Shen YC, Kuo PC, et al. Total synthesis and biological evaluation of viscolin, a 1,3-diphenylpropane as a novel potent anti-inflammatory agent. Bioorg Med Chem Lett. 2006 Dec 15;16(24):6155-60. Epub 2006 Oct 12.
28. Hwang TL, Leu YL, Kao SH, Tang MC, Chang HL. Viscolin, a new chalcone from Viscum coloratum, inhibits human neutrophil superoxide anion and elastase release via a cAMP-dependent pathway. Free Radic Biol Med. 2006 Nov 1;41(9):1433-41. Epub 2006 Aug 7.
29. Prieto JM, Recio MC, Giner RM, Máñez S, Giner-Larza EM, Ríos JL. Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions. J Pharm Pharmacol. 2003 Sep;55(9):1275-82.
30. Liu JH, Zschocke S, Reininger E, Bauer R. Inhibitory effects of Angelica pubescens f. biserrata on 5-lipoxygenase and cyclooxygenase. Planta Med. 1998 Aug;64(6):525-9.
31. Chen YF, Tsai HY, Wu TS. Anti-inflammatory and analgesic activities from roots of Angelica pubescens. Planta Med. 1995 Feb;61(1):2-8.
32. Ko FN, Wu TS, Liou MJ, Huang TF, Teng CM. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens. Thromb Haemost. 1989 Nov 24;62(3):996-9.
33. Kosuge T, Yokota M, Sugiyama K, Yamamoto T, Mure T, Yamazawa H. Studies on bioactive substances in crude drugs used for arthritic diseases in traditional Chinese medicine. II. Isolation and identification of an anti-inflammatory and analgesic principle from the root of Angelica pubescens Maxim. Chem Pharm Bull (Tokyo). 1985 Dec;33(12):5351-4.
34. Zhou J, Chen C, Su J, Yin H. Kinetics of pharmacologic effects of radix Aconiti Lateralis Preparata and sini decoction. Zhongguo Zhong Yao Za Zhi. 1992 Feb;17(2):104-7, 127.
35. Wang CF, Gerner P, Wang SY, Wang GK. Bulleyaconitine A isolated from aconitum plant displays long-acting local anesthetic properties in vitro and in vivo. Anesthesiology. 2007 Jul;107(1):82-90.
36. Lin JS, Chan CY, Yang C, Wang YH, Chiou HY, Su YC. Zhi-fuzi, a cardiotonic Chinese herb, a new medical treatment choice for portal hypertension? Exp Biol Med (Maywood). 2007 Apr;232(4):557-64.
37. Pashinski VG, Ga damovich NN, Povet'eva TN, et al. The influence of aconitum preparations on the development of chronic inflammation. Eksp Klin Farmakol. 2006 Mar-Apr;69(2):55-7.
38. Sampson JH, Phillipson JD, Bowery NG, O'Neill MJ, Houston JG, Lewis JA. Ethnomedicinally selected plants as sources of potential analgesic compounds: indication of in vitro biological activity in receptor binding assays. Phytother Res. 2000 Feb;14(1):24-9.

All contents Copyright © 2008 Tango Advanced Nutrition, Inc. All rights reserved. AllerPhase®, ArthriPhase™, BronchoPhase®, CardioPhase®, Daily Movement™, FemmePhase®, Herbal Boost™, ImmunoPhase®, MetaPhase®, OsteoPhase®, PriaPlex®, Pure Tango®, Sleep Cycle™, Tango® and Vital Cell® are registered trademarks of Tango Advanced Nutrition, Inc. The content provided by this site is for informational purposes only and has not been approved by the U.S. FDA. This site is not intended to provide personal medical advice, which should be obtained from a medical professional.